翻訳と辞書 |
CoStim
CoStim was a biotechnology company based in Cambridge, Massachusetts whose focus was cancer immunotherapy, that is, drugs that harnessed a patient’s own immune system. In particular, the company sought drugs that blocked the signals from cancer that shut down the immune response. One of the products the company worked on targeted the immune checkpoint molecule PD1. The company was involved in monoclonal antibody drug development. oStim was founded in 2012 by the venture capital firm MPM Capital as well as cancer researchers from the Dana–Farber Cancer Institute and Brigham and Women's Hospital. Later Atlas Venture also invested in the company. CoStim was acquired by the major pharmaceutical company Novartis for an undisclosed sum in February 2014. ==References==
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「CoStim」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|